Pluvicto

Ended Awarded Last action

Contract number
36C25024N0010
Awardee
Awarding agency
Obligated
$975,163

Award facts

Contract value 100% obligated
$975,162.86 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 -$225,943
Supplemental Agreement for work within scope P00001 $454,472
Original award $746,633

About this award

This federal contract award is for the procurement of the radiopharmaceutical product PLUVICTO, which is used in cancer treatment and diagnostic imaging. The contract was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of nuclear medicine products, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) as a Blanket Purchase Agreement (BPA) call.

The contract has a total ceiling value of $975,162.86 and a period of performance ending on September 30, 2024. Advanced Accelerator Applications USA Inc. is an established provider of specialized radiopharmaceuticals to federal healthcare agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH). This contract award is not set aside for small businesses, as the company is a large, specialized manufacturer in the nuclear medicine field. The contract is part of a larger BPA with the VA Integrated Service Network 10, valued at up to $7.8 million, which facilitates the flexible ordering of critical radiopharmaceuticals across federal healthcare facilities.

Quick answers

Who was awarded contract 36C25024N0010?

36C25024N0010 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2023.

How much is contract 36C25024N0010 worth?

The government has obligated $975,163 on 36C25024N0010.

Is contract 36C25024N0010 an order under another contract?

Yes. 36C25024N0010 is a BPA call under 36F79719D0169-36C25023A0020, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25024N0010 competed?

The extent of competition for 36C25024N0010 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award